EcoDrugPlus

Adrenoceptor Beta 3a

Ensembl ID : ENSXMAG00000019542
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSXMAG00000009158
Gene Symbol: LOC102229660
3 Cross references
343 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSXMAG00000009184
Gene Symbol: LOC102229920
3 Cross references
345 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSXMAG00000001363
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSXMAG00000021133
Gene Symbol: LOC102221221
3 Cross references
202 Possible Orthologues:

Alpha-2a Adrenergic Receptor

Ensembl ID : ENSXMAG00000020215
Gene Symbol: LOC102219330
3 Cross references
176 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSXMAG00000020317
Gene Symbol: LOC102230342
3 Cross references
174 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSXMAG00000005328
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSXMAG00000012674
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSXMAG00000012019
Gene Symbol: LOC102232862
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSXMAG00000023442
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSXMAG00000002896
Gene Symbol: LOC102223598
2 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).